Active ingredientCloperastine HydrochlorideCat. No. P-C216-001CAS 14984-68-0Family · Pharmaceutical analytical standards
Cloperastine
A cough suppressant with antihistamine and anticholinergic properties, from the benzhydryl ether family: it was first introduced in Japan in 1972 and later, in 1981, in Italy. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Its mechanism is not fully clear: besides blocking histamine H1 receptors it binds sigma-1 receptors and blocks GIRK potassium channels, actions that may explain its effect on cough.
Go to the active ingredient →Active ingredientCloperastine HydrochlorideCat. No. P-C216-001CAS 14984-68-0
Isotopically labelled(S)-Cloperastine-d10Cat. No. P-C216-002
Isotopically labelledCloperastine-d4 HClCat. No. P-C216-003
NitrosamineCloperastine N-Nitroso Open Ring ImpurityCat. No. P-C216-004
Impurity(S)-CloperastineCat. No. P-C216-005CAS 132301-89-4
Impurity(S)-Cloperastine FendizoateCat. No. P-C216-006CAS 220329-19-1
ImpurityCloperastine Impurity 1Cat. No. P-C216-007CAS 5630-78-4
Impurity3-ChlorobenzophenoneCat. No. P-C216-008CAS 1016-78-0
ImpurityCloperastine FendizoateCat. No. P-C216-009CAS 85187-37-7
ImpurityCloperastine Impurity 2Cat. No. P-C216-010No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.